SCHEMBL11199713

SCHEMBL11199713

CC1C=C(c2ccccc2)c2cc(Cl)ccc2-n2cnnc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 6/20 0.49
PDE4D Q08499 2/20 0.49
CCKBR P32239 3/20 0.42
HSD11B1 P28845 1/20 0.37
NR1I2 O75469 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37
PTGS2 P35354 1/20 0.37
CHRNA4 P43681 1/20 0.37
SLC6A3 Q01959 1/20 0.37
LMNA P02545 2/20 0.37
PDE3A Q14432 1/20 0.37
GABRA5 P31644 3/20 0.36
BRD4 O60885 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160251 0.79 OPRK1 (0.58) OPRK1PDE4DCCKBRNR1I2ADORA3
SCHEMBL7895739 0.72 OPRK1 (0.56) OPRK1PDE4DCCKBRNR1I2ADORA3
SCHEMBL11034765 0.71 OPRK1 (0.55) OPRK1PDE4DCCKBRNR1I2ADORA3
SCHEMBL10811993 0.71 OPRK1 (0.55) OPRK1PDE4DCCKBRNR1I2ADORA3
SCHEMBL11116621 0.71 OPRK1 (0.54) OPRK1PDE4DCCKBRNR1I2ADORA3
SCHEMBL11191653 0.71 CYP3A4 (0.43) OPRK1PDE4DCCKBRHSD11B1KCNH2
SCHEMBL18770593 0.71 OPRK1 (0.50) OPRK1PDE4DCCKBRADRA1ALMNA
SCHEMBL11827799 0.71 OPRK1 (0.60) OPRK1PDE4DCCKBRHSD11B1NR1I2
SCHEMBL11827795 0.71 OPRK1 (0.60) OPRK1PDE4DCCKBRHSD11B1NR1I2
SCHEMBL11713995 0.70 OPRK1 (0.53) OPRK1PDE4DCCKBRNR1I2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0072029-A2 Triazolobenzazepines, process and intermediates for their preparation and medicines containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1983-02-16 EP disclosed